Skip to main content
. 2020 Apr 23;95:294–300. doi: 10.1016/j.ijid.2020.04.047

Table 2.

Clinical features of mothers with COVID-19 infection

Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7 Patient 8 Patient 9 Patient 10 n
Date of admission 11-Feb 10-Feb 8-Feb 1-Feb 26-Jan 25-Jan 5-Feb 28-Jan 26-Jan 23-Jan
Age (years) 31 29 30 35 29 31 30 29 30 29
Gestational age on admission(w) 34 + 6 40 + 3 38 + 0 33 + 6 39 + 6 38 + 2 34 + 6 39 + 1 39 + 1 40 + 5
Epidemiological history Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 10
Date of delivery 11-Feb 10-Feb 9-Feb 1-Feb 27-Jan 26-Jan 6-Feb 29-Jan 26-Jan 24-Jan
Signs and symptoms
Fever Yes No No Yes Yes Yes No Yes Yes Yes 7
Prenatal fever (on admission) Yes No No Yes No No No No No No 2
Post-partum fever No No No No Yes Yes No Yes Yes Yes 5
Maximum body temperature
Low grade fever (37.3 -38.0 °C) Yes No No Yes No No No No Yes No 3
Moderate grade fever (38.1 -39.0 °C) No No No No Yes Yes No No No Yes 3
High grade fever (>39.1 °C) No No No No No No No Yes No No 1
Fever duration 3 h - - 12 h 14d 6 d - 7 d 2 d 6 d
Cough No No No No No No No No No Yes 1
Chest tightness No No No No No No No No No Yes 1
Fatigue No No No No No No No No No Yes 1
Laboratory characteristics
Lymphocyte count (× 109) (admission) 2.33 1.82 1.33 1.12 1.15 2.19 1.35 1.27 1.46 0.97 1
Lymphopenia (<1.0 × 109) (after delivery) 1.76 0.78 0.65 1.12 0.63 2.36 1.89 0.54 0.68 0.98 6
White blood cell count (× 109) 9.7 9.75 10.47 5.9 11.51 8.65 9.35 9.23 6.62 8.12
CRP (mg/L) 3.72 8.37 5.61 1.96 20.48 0.93 3.12 74.6 19.56 7.5
ALT (U/L) 14.9 10.4 8.7 9.1 5.3 3.9 9.2 6.9 17.7 9.1
AST (U/L) 22.5 14.7 16.5 23.7 12.6 10.4 21 12.6 28.2 16.9
Lactate dehydrogenase (U/L) 239.3 192.0 170.3 195.0 169.8 153.0 242.0 195.5 196.3 150.9
D-dimer (ug/L) 4.77 2.16 2.00 1.05 1.31 0.93 6.48 1.94 1.31 0.99
Mixed infection with other pathogens Mycoplasma Mycoplasma1 Mycoplasma - - - Mycoplasma Mycoplasma - Mycoplasma 6